Sargent Investment Group, LLC Denali Therapeutics Inc. Transaction History

Sargent Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $185,048 - $298,603	-3,817 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$50.3 - $78.44 $191,995 - $299,405	3,817 New	3,817 $299,000
Q1 2021 May 04, 2021	SELL	$53.8 - $81.53 $141,009 - $213,690	-2,621 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$36.89 - $93.56 $96,688 - $245,220	2,621 New	2,621 $220,000

214

121M

127K

38.3K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.95B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Investment Group, LLC with notifications on news.